Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Jul 12

PMID 34249710

Citations 6

Authors

Xinrong Lin

Xiaosong Xiang

Bing Feng

Hao Zhou

Ting Wang

Xiaoyuan Chu

Rui Wang

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma is the fifth-ranked cancer worldwide with a relatively low five-year survival rate. Long non-coding RNAs are a group of RNAs with remarkable aberrant expression which could act on multiple bioprocesses and ultimately impact upon tumor proliferation, invasion, migration, metastasis, apoptosis, and therapy resistance in cancer cells including hepatocellular carcinoma cells. In recent years, long non-coding RNAs have been reported to be indispensable targets in clinical target therapy to stop the growth of cancer and prolong the lifespan of patients with hepatocellular carcinoma. In this review, we enumerate the signaling pathways and life activities affected by long non-coding RNAs in hepatocellular carcinoma cells to illustrate the role of long non-coding RNAs in the development and therapy resistance of hepatocellular carcinoma.

Citing Articles

promotes esophageal carcinoma through regulating signaling.

Tang Z, Jiang Y, Zong Y, Ding S, Wu C, Tang Z Epigenomics. 2024; 16(17):1133-1148.

PMID: 39234955 PMC: 11457597. DOI: 10.1080/17501911.2024.2388018.

Circular RNAs-New Kids on the Block in Cancer Pathophysiology and Management.

Szczepaniak A, Bronisz A, Godlewski J Cells. 2023; 12(4).

PMID: 36831219 PMC: 9953808. DOI: 10.3390/cells12040552.

accelerates the progression of hepatocellular carcinoma through the / axis.

Li X, Fang J, Wei G, Chen Y, Li D J Gastrointest Oncol. 2022; 13(4):1875-1888.

PMID: 36092323 PMC: 9459201. DOI: 10.21037/jgo-22-677.

Novel lncRNA SNHG16 Promotes the Growth and Metastasis of Malignant Melanoma by Regulating miR-205-5p/PAK2 Axis.

Xia Y, Guan J, Lu X, Liu Y, Luan W Clin Cosmet Investig Dermatol. 2022; 15:1615-1625.

PMID: 35983126 PMC: 9379127. DOI: 10.2147/CCID.S374404.

The Role of Macroautophagy and Chaperone-Mediated Autophagy in the Pathogenesis and Management of Hepatocellular Carcinoma.

Karampa A, Goussia A, Glantzounis G, Mastoridou E, Anastasopoulos N, Charchanti A Cancers (Basel). 2022; 14(3).

PMID: 35159028 PMC: 8833636. DOI: 10.3390/cancers14030760.

References

Chang L, Wang G, Jia T, Zhang L, Li Y, Han Y . Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma. Oncotarget. 2016; 7(17):23988-4004. PMC: 5029679. DOI: 10.18632/oncotarget.8115. View

Zhou Y, Zhong Y, Wang Y, Zhang X, Batista D, Gejman R . Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007; 282(34):24731-42. DOI: 10.1074/jbc.M702029200. View

Hartke J, Johnson M, Ghabril M . The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017; 34(2):153-159. DOI: 10.1053/j.semdp.2016.12.011. View

Wu M, Lin Z, Li X, Xin X, An J, Zheng Q . HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2. Sci Rep. 2016; 6:36045. PMC: 5080550. DOI: 10.1038/srep36045. View

Liu X, Liu Z, Sun M, Liu J, Wang Z, De W . The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 2013; 13:464. PMC: 3851855. DOI: 10.1186/1471-2407-13-464. View

Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F . Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget. 2017; 8(16):26079-26089. PMC: 5432239. DOI: 10.18632/oncotarget.15317. View

Iguchi T, Uchi R, Nambara S, Saito T, Komatsu H, Hirata H . A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res. 2015; 35(3):1385-8. View

Zaimy M, Saffarzadeh N, Mohammadi A, Pourghadamyari H, Izadi P, Sarli A . New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017; 24(6):233-243. DOI: 10.1038/cgt.2017.16. View

Chen L, Yao H, Wang K, Liu X . Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression. J Cell Biochem. 2017; 118(12):4836-4843. DOI: 10.1002/jcb.26158. View

10.

Zheng Z, Pang C, Yang Y, Duan Q, Zhang J, Liu W . Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Int Med Res. 2017; 46(1):348-356. PMC: 6011314. DOI: 10.1177/0300060517726441. View

11.

Han J, Xie C, Pei T, Wang J, Lan Y, Huang K . Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis. Cell Death Dis. 2017; 8(4):e2736. PMC: 5477574. DOI: 10.1038/cddis.2017.126. View

12.

Cheetham S, Gruhl F, Mattick J, Dinger M . Long noncoding RNAs and the genetics of cancer. Br J Cancer. 2013; 108(12):2419-25. PMC: 3694235. DOI: 10.1038/bjc.2013.233. View

13.

Xiong H, Ni Z, Jiang S, Li X, He J, Gong W . LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene. 2017; 36(25):3528-3540. DOI: 10.1038/onc.2016.521. View

14.

Yang T, He X, Chen A, Tan K, Du X . RETRACTED: LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1. Gene. 2018; 670:114-122. DOI: 10.1016/j.gene.2018.05.061. View

15.

Chen S, Wang Y, Zhang J, Xia Q, Sun Q, Li Z . Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways. Oncol Lett. 2017; 14(4):4659-4662. PMC: 5649540. DOI: 10.3892/ol.2017.6823. View

16.

Chen C, Tseng Y, Wu J, Chen G, Lin K, Hwang S . Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. Biomaterials. 2015; 44:71-81. DOI: 10.1016/j.biomaterials.2014.12.023. View

17.

Llovet J, Montal R, Sia D, Finn R . Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018; 15(10):599-616. DOI: 10.1038/s41571-018-0073-4. View

18.

Wang B, Lv Z, Ding H, Fang X, Wen J, Xu Q . The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis. Gene. 2018; 670:148-154. DOI: 10.1016/j.gene.2018.05.096. View

19.

Benson A, DAngelica M, Abbott D, Abrams T, Alberts S, Anaya D . Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. J Natl Compr Canc Netw. 2019; 17(4):302-310. DOI: 10.6004/jnccn.2019.0019. View

20.

Quagliata L, Matter M, Piscuoglio S, Arabi L, Ruiz C, Procino A . Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2013; 59(3):911-23. PMC: 3943759. DOI: 10.1002/hep.26740. View